Life Science Investing Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock 11 September
Life Science Investing Avidity Biosciences Announces Proposed Public Offering of Common Stock 10 September
Life Science Investing Avidity Biosciences' Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE Phase 1/2 Trial in People Living with DMD44 10 September
